SEC Form 4 · accession 0001179022-16-000124
GALECTIN THERAPEUTICS INC · GALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Harold H. Shlevin
Officer — Chief Operating Officer
Period of report
Dec 3, 2016
Accepted (ET)
Dec 6, 2016 · 5:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001133416
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $0.87 | Dec 3, 2016 | A | 150,000 | A | — | Dec 3, 2026 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1The options vest as follows: 25% immediately, 25% on July 1, 2017, and 50% on December 31, 2017.